United Therapeutics Corp (UTHR)

129.10
NASDAQ : Health Care
Prev Close 131.06
Day Low/High 128.79 / 131.27
52 Wk Low/High 110.90 / 169.89
Avg Volume 579.60K
Exchange NASDAQ
Shares Outstanding 43.44M
Market Cap 5.69B
EPS 16.30
P/E Ratio 14.29
Div & Yield N.A. (N.A)

Latest News

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NasdaqGS:UTHR).

UTHR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation

UTHR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether United Therapeutics Corporation ("United Therapeutics") (NASDAQ:UTHR) violated federal securities laws.

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of United Therapeutics Corporation

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of United Therapeutics Corporation

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of United Therapeutics Corporation ("United Therapeutics" or the "Company") (Nasdaq:...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation -- UTHR

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of United Therapeutics Corporation -- UTHR

Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR) concerning possible violations of federal securities laws.

UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation For Potential Securities Law Violations

UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation For Potential Securities Law Violations

Girard Gibbs LLP is investigating potential claims on behalf of investors of United Therapeutics Corporation (NASDAQ:UTHR) regarding possible securities law violations.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against United Therapeutics Corporation - UTHR

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against United Therapeutics Corporation - UTHR

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of United Therapeutics Corporation (NASDAQ: UTHR) resulting from allegations that United...

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions

The Justice Department is investigating the company's charitable contributions for kickbacks and false claims.

Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector -Biotech Movers

Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector -Biotech Movers

Alexion Pharmaceuticals, United Therapeutics and Gilead Sciences were among the biotech stock movers in premarket trading on July 27.

Biotech Movers: Novocure, United Therapeutics, Kite Pharma

Biotech Movers: Novocure, United Therapeutics, Kite Pharma

Novocure, United Therapeutics and Kite Pharma were among the biotech stock movers in early trading Monday.

United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump

Conference Call Scheduled for 9:00 AM on April 3, 2017

United Therapeutics Stock Slumping on Credit Suisse Rating

United Therapeutics Stock Slumping on Credit Suisse Rating

Credit Suisse initiated United Therapeutics with an 'underperform' rating.

Analysts' Actions -- FedEx, GoPro, Garmin, HP and More

Analysts' Actions -- FedEx, GoPro, Garmin, HP and More

Here are Monday's top research calls, including upgrades for FedEx, Garmin and HP, and a downgrade for GoPro.